University of Pittsburgh researchers have developed a sustained-release wound healing therapy that can deliver TGF-β3 (Transforming Growth Factor) via nanoparticles at surgical sites, aiming to promote regenerative tissue repair, enhance tensile strength, and reduce post-operative scarring in soft tissues.